Next, we linked the corresponding precursor proteins of these peptides to a well-known association in GBM and, as a result, selected seven GFAP peptides and one EGFR peptide as targets for the Ab–peptide binding assay (Supplementary Table S2) [20,21,22,23]. The gene discussed is EGFR; the disease is glioblastoma.